home / stock / eprx:cc / eprx:cc quote
Last: | $1.05 |
---|---|
Change Percent: | 0.0% |
Open: | $0 |
Close: | $0 |
High: | $0 |
Low: | $0 |
Volume: | 6 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$1.05 | $0 | $0 | $0 | $0 | 6 | 08-02-2022 |
$1.3 | $1.44 | $1.3 | $1.65 | $1.3 | 121,313 | 05-06-2022 |
$1.27 | $1.5 | $1.27 | $1.5 | $1.26 | 16,672 | 05-05-2022 |
$1.53 | $1.48 | $1.53 | $1.53 | $1.48 | 361 | 05-04-2022 |
$1.5 | $1.54 | $1.5 | $1.64 | $1.41 | 14,648 | 05-03-2022 |
$1.5 | $1.42 | $1.5 | $1.55 | $1.21 | 613,386 | 05-02-2022 |
$1.48 | $1.53 | $1.48 | $1.61 | $1.48 | 24,780 | 04-29-2022 |
$1.59 | $1.66 | $1.59 | $1.67 | $1.45 | 6,028 | 04-28-2022 |
$1.55 | $1.48 | $1.55 | $1.63 | $1.4 | 30,011 | 04-27-2022 |
$1.5 | $1.62 | $1.5 | $1.72 | $1.5 | 11,900 | 04-25-2022 |
$1.5 | $1.6 | $1.5 | $1.6 | $1.5 | 17,569 | 04-22-2022 |
$1.61 | $1.62 | $1.61 | $1.7 | $1.6 | 7,745 | 04-21-2022 |
$1.65 | $1.7 | $1.65 | $1.7 | $1.65 | 18,271 | 04-20-2022 |
$1.84 | $1.77 | $1.84 | $1.84 | $1.66 | 9,992 | 04-19-2022 |
$1.85 | $1.95 | $1.85 | $1.95 | $1.75 | 15,523 | 04-18-2022 |
$1.7 | $1.7 | $1.7 | $1.7 | $1.62 | 1,734 | 04-15-2022 |
$1.7 | $1.7 | $1.7 | $1.7 | $1.62 | 1,331 | 04-14-2022 |
$1.59 | $1.67 | $1.59 | $1.69 | $1.59 | 186,603 | 04-13-2022 |
$1.59 | $1.86 | $1.59 | $1.9 | $1.59 | 158,910 | 04-12-2022 |
$2.05 | $2.06 | $2.05 | $2.12 | $1.99 | 38,089 | 04-11-2022 |
News, Short Squeeze, Breakout and More Instantly...
Eupraxia Pharmaceuticals Inc. Company Name:
EPRX:CC Stock Symbol:
TSXC Market:
Eupraxia Pharmaceuticals Inc. Website:
Eupraxia Pharmaceuticals to Present at Controlled Release Society 2024 Annual Meeting and Expo Canada NewsWire VICTORIA, BC , July 8, 2024 /CNW/ - Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX) (NASDAQ: EPRX), a clinical-stage biotechnolo...
Eupraxia Pharmaceuticals' CEO Dr. James Helliwell to Participate in Webinar Event, "Exploring the Rapid Rise of Osteoarthritis" on July 9, 2024 Canada NewsWire Osteoarthritis ("OA") is the leading cause of disability in older adults. The U.S. Centers for Disease Control an...
Eupraxia Pharmaceuticals Announces Voting Results from Annual General and Special Meeting of Shareholders Canada NewsWire VICTORIA, BC , June 6, 2024 /CNW/ - Eupraxia Pharmaceuticals Inc. (" Eupraxia " or the " Company ") (TSX: EPRX) (NASDAQ: EPRX), a cli...